Lipid-based drug delivery systems in cancer therapy: what is available and what is yet to come

P Yingchoncharoen, DS Kalinowski… - Pharmacological …, 2016 - ASPET
Cancer is a leading cause of death in many countries around the world. However, the
efficacy of current standard treatments for a variety of cancers is suboptimal. First, most …
被引用次数：730 相关文章

Lipid-based drug delivery systems in cancer therapy: What is available and what is yet to come

P Yingchoncharoen, DS Kalinowski… - Pharmacological …, 2016 - researchoutput.csu.edu.au
Cancer is a leading cause of death in many countries around the world. However, the
efficacy of current standard treatments for a variety of cancers is suboptimal. First, most …

[引用][C] Lipid-based drug delivery systems in cancer therapy: What is available and what is yet to come

P Yingchoncharoen, DS Kalinowski… - Pharmacological …, 2016 - elibrary.ru
[HTML] nih.gov

[HTML][HTML] Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come

P Yingchoncharoen, DS Kalinowski… - Pharmacological …, 2016 - ncbi.nlm.nih.gov
Cancer is a leading cause of death in many countries around the world. However, the
efficacy of current standard treatments for a variety of cancers is suboptimal. First, most …

Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.

P Yingchoncharoen, DS Kalinowski… - Pharmacological …, 2016 - europepmc.org
Cancer is a leading cause of death in many countries around the world. However, the
efficacy of current standard treatments for a variety of cancers is suboptimal. First, most …

[引用][C] Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come

P Yingchoncharoen, DS Kalinowski… - Pharmacological …, 2016 - cir.nii.ac.jp
Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to
Come | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …

Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come

P Yingchoncharoen, DS Kalinowski… - Pharmacological …, 2016 - pubmed.ncbi.nlm.nih.gov
Cancer is a leading cause of death in many countries around the world. However, the
efficacy of current standard treatments for a variety of cancers is suboptimal. First, most …
[PDF] csu.edu.au

[PDF][PDF] Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come

PHARMACOLOGICAL REVIEWS, 2016 - researchoutput.csu.edu.au
Cancer is a leading cause of death in many countries around the world. However, the
efficacy of current standard treatments for a variety of cancers is suboptimal. First, most …